Today: 4 June 2026
Browse Category

NASDAQ:ASND 9 December 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma shares fell 4.2% to around $197.25 in late trading December 9 after a Q3 earnings miss and a three-month FDA review delay for its key dwarfism drug. Volume was about 76% below average. The company posted Q3 revenue of €213.6 million but reported a net loss of €61 million, mainly from finance expenses. Despite the pullback, ASND remains near its 52-week high and up year-on-year.

Stock Market Today

  • Dollar Rallies to 1.75-Month High on Crude Prices and Strong U.S. Economic Data
    June 4, 2026, 12:31 PM EDT. The U.S. dollar index surged 0.31% to a 1.75-month high on Wednesday, boosted by a 2% increase in WTI crude oil prices and robust U.S. economic indicators, including stronger-than-expected May ADP employment, ISM services index, and April factory orders. Rising crude prices raise inflation expectations, potentially prompting the Federal Reserve to maintain a hawkish monetary policy stance. Middle East tensions also lent safe-haven support to the dollar after U.S. military action against Iranian targets. The euro weakened 0.27% amid dollar strength and rising oil prices, which weigh on Europe's energy-reliant economy. Eurozone data showed faster producer price inflation and a revised PMI, pushing markets to price in a near-certain ECB rate hike in June. The yen dropped to a one-month low against the dollar due to higher crude prices and rising U.S. Treasury yields, both adverse for Japan's energy-dependent economy.

Latest articles

Nu Holdings Gains on $1 Billion Buyback, Wall Street Cautious

4 June 2026
Shuttle Pharmaceuticals shares slid 3.2% to $0.507 as investors questioned its abrupt pivot from cancer-drug development to Dogecoin and Litecoin mining, with the stock trading well below the $1.03–$1.24 conversion prices in recent merger and financing deals and the company warning of substantial doubt about its ability to continue as a going concern.
High demand wipes out U.S. Mint $5,370 gold coin in minutes

High demand wipes out U.S. Mint $5,370 gold coin in minutes

4 June 2026
The U.S. Mint’s new $5,370 one-ounce American Eagle gold coin sold out in under two minutes, highlighting surging demand for physical gold investment, which Metals Focus says will overtake jewelry as the top gold demand driver this year; spot gold rose 1.7% to $4,505.35, but analysts warn high rates and a stronger dollar could pressure prices and premiums.
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

4 June 2026
Recursion shares surged about 12% to $3.87 on heavy volume ahead of its June 9 Goldman Sachs healthcare conference appearance, as investors look for updates on clinical timing, cash runway, and partnerships; small insider-sale filings were disclosed, and the move comes amid a broader rally in healthcare and AI drug-discovery stocks.
PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH Drops Hard as Calvin Klein Parent Issues Warning

4 June 2026
PVH shares plunged 21% after the company slashed its annual sales outlook, blaming the Middle East conflict for a 5% EMEA revenue drop; despite beating first-quarter earnings estimates, the warning erased over a fifth of PVH’s market value as investors focused on EMEA demand risks, with the region making up 47% of sales.
Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

4 June 2026
Redwire shares soared 14.6% to $21.33 after announcing a contract with Astrobiome Space for crop research on the ISS, marking the first commercial flight of its Greenhouse system; contract value was undisclosed, leaving investors to weigh the near-term financial impact as Redwire works to convert a record $498.1 million backlog into revenue following a recent Jefferies downgrade to Hold.
Go toTop